Attainment of molecular remission: a worthwhile goal?

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence.

Nature communications·2021

Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL.

Leukemia·2017

Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition.

Oncogene·2016

Autologous Bone-Marrow Transplantation in Acute Lymphoblastic Leukaemia: 1980-89.

Leukemia & lymphoma·2016

Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial.

Blood cancer journal·2016

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Response to Comment on: "Mmrn1 expression defines a novel subset of hematopoietic stem cells and leukemia stem cells with great self-renewal potential".

Haematologica·2026

Rigosertib Reverses Hypertrophic Cardiomyopathy in Noonan Syndrome.

Circulation·2026

Variability in Adoption of Surgical Ablation of Atrial Fibrillation: An International Survey of Cardiac Surgeons.

CJC open·2026

Hepatoprotective effect of hUC-MSC secretome in LPS-induced HepG2 cells.

Iranian journal of basic medical sciences·2026

A Novel MYRF Variant Presenting With Scimitar Syndrome, Hepatopulmonary Fusion, Right-Sided Congenital Diaphragmatic Hernia, and Uterine Didelphys.

Case reports in pediatrics·2026

Tissue factor and regenerative medicine: shaping cell and extracellular vesicle-based therapeutic approaches.

Frontiers in cell and developmental biology·2026

Related Experiment Videos

Attainment of molecular remission: a worthwhile goal?

Related Concept Videos

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).

Adipocytes disrupt the translational programme of acute lymphoblastic leukaemia to favour tumour survival and persistence.

Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL.

Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition.

Autologous Bone-Marrow Transplantation in Acute Lymphoblastic Leukaemia: 1980-89.

Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial.

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3.

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.

Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.

Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.

COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.

Response to Comment on: "Mmrn1 expression defines a novel subset of hematopoietic stem cells and leukemia stem cells with great self-renewal potential".

Rigosertib Reverses Hypertrophic Cardiomyopathy in Noonan Syndrome.

Variability in Adoption of Surgical Ablation of Atrial Fibrillation: An International Survey of Cardiac Surgeons.

Hepatoprotective effect of hUC-MSC secretome in LPS-induced HepG2 cells.

A Novel MYRF Variant Presenting With Scimitar Syndrome, Hepatopulmonary Fusion, Right-Sided Congenital Diaphragmatic Hernia, and Uterine Didelphys.

Tissue factor and regenerative medicine: shaping cell and extracellular vesicle-based therapeutic approaches.

Related Experiment Videos

Attainment of molecular remission: a worthwhile goal?

Related Concept Videos

Related Articles